23andMe
North America, California, United States, Sunnyvale
Description
23andMe is a DNA testing technology company that enables its users to access their ancestry, genealogy, and inherited traits.
Investor Profile
23andMe has backed more than 2 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 1 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series B rounds (top funding stages).
- Majority of deals are located in United Kingdom, United States.
- Strong thematic focus on Career Planning, Corporate Training, EdTech.
Stage Focus
- Series B (100%)
Country Focus
- United Kingdom (50%)
'%3e%3cpath fill='%23012169' d='M0 0v30h60V0z'/%3e%3cpath stroke='%23fff' stroke-width='6' d='m0 0 60 30m0-30L0 30'/%3e%3cpath stroke='%23C8102E' stroke-width='4' d='m0 0 60 30m0-30L0 30' clip-path='url(%23b)'/%3e%3cpath stroke='%23fff' stroke-width='10' d='M30 0v30M0 15h60'/%3e%3cpath stroke='%23C8102E' stroke-width='6' d='M30 0v30M0 15h60'/%3e%3c/g%3e%3c/svg%3e)
- United States (50%)
Industry Focus
- Career Planning
- Corporate Training
- Edtech
- Training
- Health Care
- Hospital
- Mobile Apps
- Software
- Telehealth
- Virtualization
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
Who does 23andMe frequently co-invest with?
Which angels does 23andMe often collaborate with?
What are some of recent deals done by 23andMe?
Find More Investors Like 23andMe
Discover similar investors in our database and build your perfect investor list.
Need help with your fundraising strategy?Read our fundraising guides
